Last updated on July 2019

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)


Find a site near you

Start Over

Novartis Investigative Site

Lille Cedex, France
3.84miles
  Connect »